NCT01333228View on ClinicalTrials.gov

Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions
Liver Cirrhosis
Interventions
OTHER

Autologous bone marrow-derived endothelial progenitor cells

Intraarterial administration (hepatic artery) of autologous bone marrow-derived endothelial progenitor cells

Trial Locations (1)

31008

Clinica Universidad de Navarra, Pamplona

All Listed Sponsors
collaborator

Foundation Ramon Areces

UNKNOWN

collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT01333228 - Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis | Biotech Hunter | Biotech Hunter